Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 11 of the 16 sources its claims cite were checked for support.

Feasibility and effectiveness of a digital voice assistant for improving anti-osteoporosis medication adherence, and osteoporosis knowledge and attitudes, in postmenopausal women with osteoporosis: A 12-month randomised controlled trial

Open access

Abstract

Digital voice assistants (DVAs) are feasible for delivering a digital health intervention designed to improve osteoporosis self-management in postmenopausal women with osteoporosis. However, the DVA intervention did not improve anti-osteoporosis drug adherence, nor did it enhance osteoporosis knowledge or attitudes in this population. PURPOSE: To determine feasibility and effectiveness of a digital voice assistant (DVA) intervention for improving anti-osteoporosis medication adherence, and osteoporosis knowledge and attitudes, in postmenopausal women with osteoporosis. METHODS: This 12-month single-blinded, randomised controlled trial included 50 postmenopausal women with osteoporosis randomised to DVA (N = 25) or control (N = 25) for 6 months, followed by a 6-month follow-up period. DVA participants received an Amazon Alexa device that delivered osteoporosis education videos, medication reminders and interactive quizzes. Control participants received emails with links to osteoporosis information. Anti-osteoporosis medication possession ratio (MPR; acceptable adherence defined as ≥ 0.8) was determined using Pharmaceutical Benefits Schedule data. Osteoporosis knowledge was measured using the Osteoporosis Knowledge Assessment Tool (OKAT) and medication attitudes were measured using the Adherence Evaluation of Osteoporosis Treatment (ADEOS-12) questionnaire. RESULTS: The mean ± SD age of participants was 64.3 ± 6.1 years and 6-month DVA intervention adherence (number of DVA sessions accessed) was 79.5% (95%CI: 73.9, 84.9). The proportion of participants with acceptable 12-month MPRs was similar between groups (control: 86.4% [95%CI: 77.0, 93.6]; DVA: 95.0% [95%CI: 88.4, 100.0], P = 0.34). Mean OKAT scores improved in both groups after both 6- and 12 months, but there were no significance between groups. Changes in mean ADEOS-12 scores did not differ between baseline and 6 months in DVA compared to control (0.61 [95%CI: - 0.80, 2.03]) but worsened post-intervention from 6 to 12 months (net difference: - 1.42 [95%CI: - 2.80, - 0.06]). CONCLUSIONS: This DVA-delivered intervention achieved good adherence but did not improve medication adherence, osteoporosis knowledge, or attitudes compared with control. Future studies should target populations with poor adherence to anti-osteoporosis medication.

Overview

CoChat Summary

## TL;DR

In this 12-month randomized controlled trial of 50 postmenopausal women with osteoporosis, a digital voice assistant (DVA) was feasible and had good uptake, but it did not improve anti-osteoporosis medication adherence compared with control. Osteoporosis knowledge improved in both groups, yet the DVA did not improve overall knowledge or attitudes versus control.

## Key findings

  • The trial randomized 50 women (25 DVA, 25 control) and reported 6-month DVA intervention adherence of 79.5% (95% CI 73.9, 84.9); 20/25 (80%) DVA participants achieved at least 66% adherence.
  • At 12 months, the proportion with acceptable medication adherence (MPR ≥ 0.8) was 86.4% in control and 95.0% in DVA, with no significant difference (P = 0.34).
  • Mean OKAT scores increased in both groups from baseline to 6 months and 12 months, but there were no between-group differences at any time point.
  • ADEOS-12 attitudes did not differ from baseline to 6 months between groups, but from 6 to 12 months attitudes worsened in DVA vs control with a net difference of −1.42 (95% CI −2.80, −0.06; P = 0.04).

## Methods

  • Design: 12-month, two-arm, single-blinded randomized controlled trial with a 6-month intervention followed by a 6-month no-intervention follow-up.
  • Sample/data: 50 Australian postmenopausal women aged ≥50 with clinician-diagnosed osteoporosis and a current anti-osteoporosis prescription; adherence was measured using Pharmaceutical Benefits Schedule (PBS) data, knowledge with OKAT, and attitudes with ADEOS-12.
  • Analysis: Intention-to-treat analyses used Fisher’s exact test for adherent proportions and linear mixed models for OKAT and ADEOS-12 changes; a per-protocol analysis included only DVA participants with ≥66% intervention adherence.

## Limitations

  • The paper states the sample size was small and may have been insufficient to detect significant differences for some outcomes.
  • The authors note selection bias may have occurred because observed medication adherence was already high (>80%) and participants were relatively highly educated; this may limit generalizability to people with poorer adherence or lower education.
  • The paper says most participants were on 6- or 12-monthly denosumab or similar schedules, which may have reduced the chance of detecting an adherence effect; it also notes that control-group use of emailed educational materials was not measured, which could have masked differences.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s11657-025-01529-0

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Flow diagram demonstrating the flow of participants through the study
Fig. 1 Flow diagram demonstrating the flow of participants through the studyCC BY · PubMed Central
Fig. 2 Mean ± SD Adherence Evaluation of Osteoporosis Treatment (ADEOS-12) scores for digital voice assistant and control groups at baseline, 6, and 12 months. *indicates significant (P < 0.05) group X time interaction between 6 and 12 months
Fig. 2 Mean ± SD Adherence Evaluation of Osteoporosis Treatment (ADEOS-12) scores for digital voice assistant and control groups at baseline, 6, and 12 months. *indicates significant (P < 0.05) group X time interaction between 6 and 12 monthsCC BY · PubMed Central
Fig. 3 Mean ± SD Osteoporosis Knowledge Assessment Tool (OKAT) scores for digital voice assistant and control groups at baseline, 6 and 12 months. # Indicates significant (P < 0.05) within-group change relative to baseline
Fig. 3 Mean ± SD Osteoporosis Knowledge Assessment Tool (OKAT) scores for digital voice assistant and control groups at baseline, 6 and 12 months. # Indicates significant (P < 0.05) within-group change relative to baselineCC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 2 Not valid · 4 Not checked · 46 Own results and interpretations

25 more claims

Create a free account to see all 59 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 17
  • It may state two separate claims as one. 15

Create a free account to see these claims.

Citations

Cites

Show all 37 references

Cited by

See all 8

Metadata

Authors
Hunegnaw, M. T., Mesinovic, J., Jansons, P., George, E. S., De Ross, B., Kiss, N., Ebeling, P. R., Daly, R. M., Gvozdenko, E., & Scott, D.
Affiliations
  • Deakin University (AU)
  • Monash Health (AU)
Corresponding author
Hunegnaw, Melkamu Tamir
Venue
Archives of Osteoporosis
Published
2025-04-09
Volume
20
Issue
1
Pages
43-43
ISSN
1862-3514 (ISSN-L)
OpenAlex
W4409288289
Cited by
8
References
37
Citations by year
2026: 7 · 2025: 1
FWCI
10.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Archives of Osteoporosis (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
Deakin University
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
voice assistants, postmenopausal women, medication reminders, medication possession ratio, osteoporosis knowledge, attitudes toward medication, Amazon Alexa, digital health interventions, feasibility
MeSH terms
Aged, Feasibility Studies, Female, Humans, Health Knowledge, Attitudes, Practice, Middle Aged, Patient Education as Topic, Pilot Projects, Osteoporosis, Postmenopausal, Single-Blind Method, Speech Recognition Software, Bone Density Conservation Agents, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Feasibility and effectiveness of a digital voice assistant for improving anti-osteoporosis medication adherence, and osteoporosis knowledge and attitudes, in postmenopausal women with osteoporosis: A 12-month randomised controlled trial. https://app.cochat.ai/papers/10.1007/s11657-025-01529-0
The paper
Hunegnaw, M. T., Mesinovic, J., Jansons, P., George, E. S., De Ross, B., Kiss, N., Ebeling, P. R., Daly, R. M., Gvozdenko, E., & Scott, D. (2025). Feasibility and effectiveness of a digital voice assistant for improving anti-osteoporosis medication adherence, and osteoporosis knowledge and attitudes, in postmenopausal women with osteoporosis: A 12-month randomised controlled trial. Archives of Osteoporosis. https://doi.org/10.1007/s11657-025-01529-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.